Work

Impact of Genetic Variation in the Endocannabinoid-Degrading Enzyme FAAH on Dopamine D2/3 Receptor Status: Neuroimaging studies in Human and Mice with implications for Addictions

Year: 2020
Type: dissertation
Study design: Observational Study
Abstract: BACKGROUND: The endocannabinoid and dopaminergic systems have independently been implicated in addiction. We investigated a potential interaction between a genetically inherited variation in fatty acid amide hydrolase (FAAH C385A), the enzyme which metabolizes the endocannabinoid anandamide, and dopamine receptor status in brain. METHODS: Brain binding of the dopamine D3-preferring probe [C-11]-(+)-PHNO was measured with positron emission tomography (PET) in 79 healthy participants genotyped for the FAAH C385A polymorphism. Autoradiography with [H-3]-(+)-PHNO and in situ hybridization with a D3-specific S-35 riboprobe were carried out in a FAAH knock-in mouse model replicating the FAAH C385A polymorphism. RESULTS: Humans and knock-in mice with the C385A variant showed reduced FAAH activity demonstrated higher dopamine D3 receptors. CONCLUSIONS: Results may provide a mechanistic link between dopamine and endocannabinoid systems and explain greater risk for addiction with lower FAAH (C385A variant).
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W3159499840
Cites: 384
Cited by:
Related to: 9